Literature DB >> 33936852

Eugenol, citral, and hexanal, alone or in combination with heat, affect viability, biofilm formation, and swarming on Shiga-toxin-producing Escherichia coli.

Cindy Joanna Caballero-Prado1, Jose Angel Merino-Mascorro1, Norma Heredia1, Jorge Dávila-Aviña1, Santos García1.   

Abstract

Shiga-toxin-producing Escherichia coli strains are pathogenic for humans and cause mild to severe illnesses. In this study, the antimicrobial effect of citral, eugenol, and hexanal in combination with heat shock (HS) was evaluated in terms of the growth, biofilm formation, swarming, and expression of virulence genes of STEC serotypes (O157:H7, O103, O111, and O26). Eugenol was the most effective compound against the growth of E. coli strains (MBC = 0.58 to 0.73 mg/mL), followed by citral (MBC = 0.86 to 1.26 mg/mL) and hexanal (MBC = 2.24 to 2.52 mg/mL). Biofilm formation and swarming motility have great variability between STEC strains. Natural compounds-alone or combined with HS-inhibited biofilm formation; however, swarming motility was induced by most treatments. The expression of the studied genes during biofilm formation and swarming under natural antimicrobials was affected but not in a uniform pattern. These treatments could be used to control contamination of STEC and inhibit biofilm formation. © The Korean Society of Food Science and Technology 2021.

Entities:  

Keywords:  Biofilm; Escherichia coli; Natural product; STEC; Swarming; Virulence factor

Year:  2021        PMID: 33936852      PMCID: PMC8050133          DOI: 10.1007/s10068-021-00887-y

Source DB:  PubMed          Journal:  Food Sci Biotechnol        ISSN: 1226-7708            Impact factor:   2.391


  32 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Evaluation of combined antibacterial effects of eugenol, cinnamaldehyde, thymol, and carvacrol against E. coli with an improved method.

Authors:  Rui-Song Pei; Feng Zhou; Bao-Ping Ji; Jing Xu
Journal:  J Food Sci       Date:  2009-09       Impact factor: 3.167

Review 3.  Enterohemorrhagic Escherichia coli Infections and the Hemolytic-Uremic Syndrome.

Authors:  Andrea V Page; W Conrad Liles
Journal:  Med Clin North Am       Date:  2013-07       Impact factor: 5.456

4.  Influences of epigallocatechin gallate and citric acid on Escherichia coli O157:H7 toxin gene expression and virulence-associated stress response.

Authors:  J Yang; C B Tang; J Xiao; W F Du; R Li
Journal:  Lett Appl Microbiol       Date:  2018-10-03       Impact factor: 2.858

5.  Quantification of viable but nonculturable Escherichia coli O157:H7 by targeting the rpoS mRNA.

Authors:  Yanming Liu; Chuan Wang; Christina Fung; Xing-Fang Li
Journal:  Anal Chem       Date:  2010-04-01       Impact factor: 6.986

6.  Rhizobium sensing of airborne saturated aldehydes of different sizes modulates the response to Cd exposure.

Authors:  Diana Matos; Carina Sá; Paulo Cardoso; Adília Pires; Etelvina Figueira
Journal:  J Hazard Mater       Date:  2020-04-07       Impact factor: 10.588

7.  Cinnamon bark oil and its components inhibit biofilm formation and toxin production.

Authors:  Yong-Guy Kim; Jin-Hyung Lee; Soon-Il Kim; Kwang-Hyun Baek; Jintae Lee
Journal:  Int J Food Microbiol       Date:  2014-12-03       Impact factor: 5.277

8.  Impairment of ribosome maturation or function confers salt resistance on Escherichia coli cells.

Authors:  Yoichi Hase; Takefusa Tarusawa; Akira Muto; Hyouta Himeno
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

Review 9.  Some Like It Hot: Heat Resistance of Escherichia coli in Food.

Authors:  Hui Li; Michael Gänzle
Journal:  Front Microbiol       Date:  2016-11-03       Impact factor: 5.640

10.  Escherichia coli Remodels the Chemotaxis Pathway for Swarming.

Authors:  Jonathan D Partridge; Nguyen T Q Nhu; Yann S Dufour; Rasika M Harshey
Journal:  mBio       Date:  2019-03-19       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.